FDAFDA · Food and drugs·Recall number D-795-2013
Xylazine 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Published July 17, 2013 · Recall initiated: May 29, 2013
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recall details
- Manufacturer
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Distributor
- Nationwide and PR
- Lot
- A5025 Exp 6/2/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.